Table 2. Significant (P < 0.05) association (measured genotype approach) of SNPs with key MS-related phenotypes.

SNP	MAF (%)	Location (bp)	HDL-C	ln Leptin	FPG	FSI	SS	T2DM	BMI	ln TG	Total
rs1800949	29.9	−768			0.038						1
rs876507	1.1	2,330	0.042								1
rs4086314	28.8	3,407	0.027								1
rs6918013	6.4	9,386		0.032	0.0047						2
rs943004	4.4	11,544								0.046	1
rs7756163	48.2	13,331			0.048						1
rs6917903	30.7	18,284	0.010								1
rs1830971	41.3	19,021	0.0096								1
rs2021966	49.8	21,107	0.038					0.041			2
rs9372999	10.6	23,820	0.0068								1
rs7754609	7.9	25,598			0.020						1
rs997509	1.8	38,645				0.045					1
rs7769058	5.5	63,662							0.039		1
rs7769712	9.2	64,063	0.037								1
rs6928362	2.5	81,349		0.012			0.032				2
rs1974201	43.3	81,789		0.045							1
rs6929388	2.5	81,858		0.015			0.049				2
rs7754586	44.9	83,410		0.013							1
rs7754859	47.2	83,476		0.042							1
rs1931009	5.8	85,336						0.044			1
		Total	7	6	4	1	2	2	1	1	24

FPG, fasting plasma glucose; FSI, fasting-specific insulin; HDL-C, high-density lipoprotein cholesterol; ln, natural log-transformed; MAF, minor allele frequency; MS, metabolic syndrome; SNP, single-nucleotide polymorphisms; SS, sum of skinfold thickness; T2DM, type 2 diabetes mellitus; TG, triglyceride.

P values <0.01 are indicated in boldface.